Coinbase
COIN
MicroStrategy
MSTR
MARA Holdings
MARA
Alphabet-A
GOOGL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
SUPN Supernus Pharmaceuticals
- 37.570
- +0.650+1.76%
Trading Jan 6 11:38 ET
2.07BMarket Cap35.21P/E (TTM)
38.330High37.335Low312.80KVolume37.500Open36.920Pre Close11.82MTurnover0.66%Turnover Ratio1878.50P/E (Static)55.22MShares39.37052wk High2.06P/B1.79BFloat Cap25.53052wk Low--Dividend TTM47.73MShs Float61.250Historical High--Div YieldTTM2.70%Amplitude4.300Historical Low37.783Avg Price1Lot Size
Supernus Pharmaceuticals News
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rubin Jonathan
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rubin Jonathan
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Supernus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.25%),Steven Boyd(9.25%)
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director NEWHALL CHARLES W III
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hudson Frederick M.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GEMAYEL GEORGES
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mottola Frank
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GEMAYEL GEORGES
Supernus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Macquarie Group Limited(4.78%),Macquarie Management Holdings Inc(4.78%), etc.
Supernus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Dimensional Fund Advisors LP(5.2%)
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GEMAYEL GEORGES
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.